I am largely cashed up and considering buying IMU. I bought some at 13 cents not long ago and got out at 12.5.
It seems to me a buyout at this stage is very unlikely. I doubt the directors and large holders would accept a deal that wasn't reflecting what they think is the potential. And the potential is largely unproven. So a bid would need to be a very big gamble.
Factors that might have some bearing on the share performance in the next few weeks are tax loss selling before the end of June and possibly market manipulation. Both these being negative.
The share price is trending downwards. The realistic catalysts for improvement is announcements on trial results/success, and deals to commercialize, or possibly the FDA granting fast track approval. The latter would be next year at the earliest?
So the most likely event to turn the trend at this stage is publication or presentation of the results of the ongoing trials. I understand updates are due about now or in July.
The case for IMU as an investment must be well known to a broad section of share investors in Australia, particularly traders. The stock has performed dramatically in recent years. The cash raises and subsequent poor performance has probably soured some. But a strong fan base still exists.
So it seems to me that there are fundamentals that the shares could bounce on good trial results, perhaps double or more. With no news or less than impressive trial results I would imagine the shares drifting lower in this market.
So short term to me, the shares have a favorable upside to risk potential. In the medium term will come commercialization deals if the science is as favorable as many anticipate. The big money starts to look realistic with FDA approvals, though if results are exceptional with no safety issues we can probably anticipate this is a given for something as prevalent and dire as cancers.
So I am looking to buy in over the next 2 weeks to catch the potential rerate over results. Ideally I then hold for around 2 years if I don't trade a portion..
- Forums
- ASX - By Stock
- IMU
- IMU Target $2.00 - Not Ramping !!!
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

IMU Target $2.00 - Not Ramping !!!, page-115
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5735292 | 0.012 |
35 | 10497532 | 0.011 |
118 | 35980571 | 0.010 |
37 | 19431668 | 0.009 |
13 | 4220748 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3078567 | 8 |
0.014 | 10063029 | 39 |
0.015 | 6593187 | 20 |
0.016 | 6224494 | 27 |
0.017 | 7006978 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online